Table 2.
Variable | Number of Study | n/N | Mean (SD) | % | |
---|---|---|---|---|---|
Sign of shock | 24 | 652/1288 | 50.62 | ||
respiratory distress/failure | 24 | 270/1288 | 20.96 | ||
Radiography | Normal | 9 | 25/751 | 3.33 | |
Cardiomegaly + Pericardial effusion | 164/751 | 21.84 | |||
Pleural effusion | 105/751 | 13.98 | |||
focal/bilateral opacity | 169/751 | 22.50 | |||
lung oedema | 16/751 | 2.13 | |||
Atelectasis | 10/751 | 1.33 | |||
interstitial abnormalities | 9/751 | 1.20 | |||
Reactive airway disease | 2/751 | 0.27 | |||
Electrocardiography | Junctional rhytm | 7 | 3/212 | 1.42 | |
Sinus Bradycardia | 1/212 | 0.47 | |||
Supraventricular extrasystole | 1/212 | 0.47 | |||
Attenuated QRS | 1/212 | 0.47 | |||
AV block | 5/212 | 2.36 | |||
PR Interval abnormalities | 2/212 | 0.94 | |||
QT abnormalities | 1/212 | 0.47 | |||
T wave abnormalitis | 21/212 | 9.91 | |||
Atrial Fibrillation | 1/212 | 0.47 | |||
Ventricular arrhytmia (VT/VF/PVC) | 4/212 | 1.89 | |||
ST abnormalities | 34/212 | 16.04 | |||
Various Troponin Level | Troponin I | 3 | 869 (1229) | ||
Troponin T | 3 | 75 (132) | |||
High sensitivity troponin I | 3 | 1183 (3307) | |||
Unspecified troponin | 7 | 1277 (10114) | |||
Elevated troponin I | 4 | 50/67 | 74.63 | ||
Elevated sensitivity troponin I | 3 | 61/68 | 89.7 | ||
Elevated unspecified | 7 | 335/718 | 46.66 | ||
BNP (pg/mL) | 4 | 4238.35 (5803.24) | |||
NT-proBNP (pg/mL) | 10 | 13,590.78 (20,676.1) | |||
Echocardiography | Mitral Regurgitation | 22 | 175/1174 | 14.91 | |
Tricuspid Regurgitation | 19/1174 | 1.62 | |||
Pericardial Effusion + pericarditis | 221/1267 | 17.44 | |||
Myocarditis | 196/1267 | 15.47 | |||
RV dysfunction | 17/1174 | 1.45 | |||
Biventricular systolic dysfunction | 1/1174 | 0.09 | |||
Coronary Echogenicity | 17/1174 | 1.45 | |||
Coronary artery dilatation | 42/1174 | 3.58 | |||
Coronary artery aneurysm | 45/1267 | 3.55 | |||
Unspecified valvular regurgitation | 2/1174 | 0.17 | |||
Coronary artery dilatation or aneurysm | 95/1174 | 8.09 | |||
Biventricular or left ventricular dysfunction | 5/1174 | 0.43 | |||
Ectatic coronary artery | 14/1174 | 1.19 | |||
Myocardial dysfunction | 15/1174 | 1.28 | |||
Unspecified coronary abnormalities | 4/1174 | 0.34 | |||
Echocardiography | Cardiomegaly | 2/1174 | 0.17 | ||
Regional wall motion abnormal | 3/1174 | 0.26 | |||
Lack of distal tapering LAD coronary artery | 11/1174 | 0.94 | |||
Dilated left ventricle | 1/1174 | 0.09 | |||
Diastolic dysfunction | 2/1174 | 0.17 | |||
Left ventricle dysfunction | 107/1174 | 8.45 | |||
LVEF | > 55% | 13 | 33/305 | 10.82 | |
< 55% | 180/305 | 59.02 | |||
N/A | 80/305 | 26.23 | |||
Coronary Artery Z score |
< 2 | 13 | 11/139 | 7.91 | |
2–2.5 | 9/139 | 6.47 | |||
≥ 2.5 | 18/138 | 12.95 |
AV; atrioventricular, BNP; brain natriuretic peptide, NT-proBNP; N-terminal-pro brain natriuretic peptide, RV; right ventricular, LVEF; left ventricular ejection fraction, N/A; not available.